InVitro International, Inc. (IVRO)
OTCMKTS · Delayed Price · Currency is USD
0.06701
+0.0050 (8.08%)
Jul 30, 2026, 4:00 PM EST
InVitro International Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| 0.81 | 0.79 | 0.85 | 1 | 1.1 | |
Revenue Growth | 2.35% | -7.13% | -14.94% | -9.18% | 4.95% |
Cost of Revenue | 0.16 | 0.16 | 0.17 | 0.2 | 0.21 |
Gross Profit | 0.65 | 0.64 | 0.68 | 0.8 | 0.9 |
Selling, General & Admin | 0.53 | 0.65 | 0.71 | 0.72 | 0.8 |
Research & Development | 0.05 | 0.01 | 0.09 | 0.11 | 0.07 |
Operating Expenses | 0.59 | 0.66 | 0.8 | 0.83 | 0.87 |
Operating Income | 0.07 | -0.03 | -0.12 | -0.03 | 0.03 |
Interest & Investment Income | 0.04 | 0.03 | 0.01 | 0.01 | 0.02 |
Other Non Operating Income (Expenses) | - | - | 0.11 | - | - |
EBT Excluding Unusual Items | 0.11 | 0 | 0 | -0.02 | 0.05 |
Gain (Loss) on Sale of Investments | - | - | -0.09 | 0.01 | 0.01 |
Other Unusual Items | - | - | 0.1 | 0.11 | - |
Pretax Income | 0.11 | 0 | 0.01 | 0.11 | 0.06 |
Income Tax Expense | - | 0 | -0.01 | 0.01 | 0.01 |
Net Income | 0.11 | 0 | 0.02 | 0.1 | 0.05 |
Net Income to Common | 0.11 | 0 | 0.02 | 0.1 | 0.05 |
Net Income Growth | 6770.83% | -92.70% | -77.84% | 92.39% | -29.40% |
Shares Outstanding (Basic) | 23 | 23 | 23 | 23 | 23 |
Shares Outstanding (Diluted) | 24 | 24 | 23 | 23 | 23 |
Shares Change | -0.15% | 1.98% | 0.87% | 2.10% | 2.91% |
EPS (Basic) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS (Diluted) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Growth | 6053.85% | -93.07% | -76.54% | 100.05% | -33.37% |
Additional Metrics
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
Free Cash Flow | 0.1 | -0.06 | 0.03 | 0.03 | -0.02 |
Free Cash Flow Per Share | 0.00 | -0.00 | 0.00 | 0.00 | -0.00 |
Gross Margin | 80.55% | 80.24% | 79.69% | 80.15% | 81.24% |
Operating Margin | 8.42% | -3.20% | -13.68% | -2.67% | 2.83% |
Profit Margin | 13.15% | 0.20% | 2.49% | 9.57% | 4.52% |
Free Cash Flow Margin | 12.15% | -7.56% | 3.66% | 2.88% | -2.02% |
EBITDA | 0.07 | -0.02 | -0.11 | -0.03 | 0.03 |
EBITDA Margin | 8.96% | -2.77% | -13.34% | -2.49% | 3.10% |
D&A For EBITDA | 0 | 0 | 0 | 0 | 0 |
EBIT | 0.07 | -0.03 | -0.12 | -0.03 | 0.03 |
EBIT Margin | 8.42% | -3.20% | -13.68% | -2.67% | 2.83% |
Effective Tax Rate | - | 34.00% | - | 9.01% | 18.79% |
Advertising Expenses | 0.04 | 0.02 | 0.07 | - | 0.09 |